Exelixis (EXEL) Change in Acquisitions & Divestments (2010 - 2026)

Exelixis (EXEL) recorded quarterly Change in Acquisitions & Divestments of $225.1 million in Q2 2026, up 18.9% quarter-over-quarter from $189.3 million in Q1 2026, and down 13.05% on a YoY basis from $258.9 million in Q2 2025.

Exelixis (EXEL) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Exelixis' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $225.1 million for Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments fell 13.05% year-over-year to $225.1 million; the TTM figure through Apr 2026 stood at $989.1 million (up 13.98% YoY), while the FY2026 annual figure was $1.0 billion, up 16.59% from the prior year.
  • Change in Acquisitions & Divestments was $225.1 million for Q2 2026 at Exelixis, up from $189.3 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $353.1 million in Q3 2025 to a low of $153.5 million in Q4 2023.
  • Historically, Change in Acquisitions & Divestments has averaged $248.7 million across 5 years, with a median of $238.0 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments slumped 46.18% in 2024, then jumped 64.02% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $238.0 million in 2022, then slumped by 35.5% to $153.5 million in 2023, then rose by 9.07% to $167.4 million in 2024, then surged by 32.31% to $221.5 million in 2025, then increased by 1.63% to $225.1 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $225.1 million (Q2 2026), $189.3 million (Q1 2026), and $221.5 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 225.13 Mn
Apr 3, 2026 225.13 Mn
Jan 2, 2026 189.34 Mn
Jan 2, 2026 189.34 Mn
Oct 3, 2025 221.51 Mn
Oct 3, 2025 221.51 Mn
Jul 4, 2025 353.10 Mn
Jul 4, 2025 353.10 Mn
Apr 4, 2025 258.92 Mn
Apr 4, 2025 258.92 Mn
Jan 3, 2025 226.16 Mn
Jan 3, 2025 226.16 Mn
Sep 27, 2024 167.42 Mn
Sep 27, 2024 167.42 Mn
Jun 28, 2024 215.28 Mn
Jun 28, 2024 215.28 Mn
Mar 29, 2024 268.45 Mn
Mar 29, 2024 268.45 Mn
Dec 29, 2023 153.49 Mn
Dec 29, 2023 153.49 Mn